Indication
Hashimoto
2 clinical trials
3 products
Clinical trial
A Phase 2b, Randomized, Double-Mask, Placebo-Controlled, Study to Evaluate the Safety, Pharmacokinetics and Efficacy of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)Status: Recruiting, Estimated PCD: 2023-07-01
Product
PlaceboProduct
LinsitinibProduct
linsitinibClinical trial
A Multicenter, Extension Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)Status: Recruiting, Estimated PCD: 2026-06-01